Dr. Ilya Likhterov, MD

Dr. Likhterov practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Likhterov's NPI, 1700111382, was assigned on October 15, 2009. Dr. Likhterov graduated from Weill Cornell Medicine in 2009. Dr. Likhterov holds California license A117132.

Dr. Likhterov's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Likhterov's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Likhterov to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Likhterov practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Likhterov's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Likhterov is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Likhterov's licenses on file in 3 states: California, Minnesota and New York.

Dmand AI lists ear eustachian tube disorders, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Likhterov treats.

CMS data shows 230 Medicare services from Dr. Likhterov across 7 procedure codes in 2024, for 188 Medicare patients. Medicare paid $18,939 for them.

CMS counts 188 Medicare patients who saw Dr. Likhterov in 2024. The largest group is 65 to 74, with 79 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Likhterov's median patient age at 68, with 45% women.

In 2024, Dr. Likhterov wrote 253 Medicare Part D claims for 135 patients. 98% of them were for generic drugs. CMS names the drug for 182 of them, across 8 drugs with 11 or more claims each, at $2,857 in total drug cost. In 2023, CMS named 252 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Likhterov for performance year 2024, reported as part of a group. Dr. Likhterov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Likhterov as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Likhterov, published from 2011 to 2021. 2016 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Thyroid Neoplasms and Plastic Surgery Procedures. Dr. Likhterov has published most often in Laryngoscope. Dr. Likhterov's most frequent co-authors are Mark Lawrence Urken, MD, Raymond L. Chai, MD and Katherine C. Yung, MD.

CMS Open Payments shows 36 general payments to Dr. Likhterov from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Inspire Medical Systems, Inc. paid the most, $565.

Dr. Likhterov serves on Residency Competency Committee.

Dr. Likhterov graduated from Weill Cornell Medicine in 2009.

Dr. Likhterov is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.